Prescription drug · ANDA
Isosorbide Dinitrate NDC 0904-6620
Isosorbide dinitrate 20 mg/1 · Tablet · Oral · Major Pharmaceuticals
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0904-6620-61 | 00904662061 | 100 BLISTER PACK in 1 CARTON (0904-6620-61) / 1 TABLET in 1 BLISTER PACKMarketed from Apr 26, 1983 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Isosorbide Dinitrate
- Generic name (nonproprietary)
- isosorbide dinitrate
- Active ingredients
- Isosorbide dinitrate — 20 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Major Pharmaceuticals
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 088088
- Marketing start
- Listing expires
- Other FDA classes
- Nitrates (Chemical structure)Vasodilation (Physiologic effect)
- Identifiers
- Product ID 0904-6620_43289136-625e-4671-b4c8-bb523c11b132SPL ID 43289136-625e-4671-b4c8-bb523c11b132SPL set ID 6c4997e7-9ce6-46a6-a9c1-4bd3d76155ebRxCUI 206842, 381056UNII IA7306519N
- Pharmacologic class
- Nitrate Vasodilator
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400904662061followed by a unit qualifier and the quantityPackage 00904-6620-61. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Isosorbide Dinitrate Tablets, USP are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of immediate-release oral isosorbide dinitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 088088
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Isosorbide Dinitrate | Isosorbide dinitrate 20 mg/1 | TabletOral | Cardinal Health 107, LLC | 55154-7991 |
| Isosorbide Dinitrate | Isosorbide dinitrate 10 mg/1 | TabletOral | Cardinal Health 107, LLC | 55154-7990 |
| Isosorbide Dinitrate | Isosorbide dinitrate 10 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-148 |
| Isosorbide Dinitrate | Isosorbide dinitrate 5 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-147 |
| Isosorbide Dinitrate | Isosorbide dinitrate 20 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-149 |
| Isosorbide Dinitrate | Isosorbide dinitrate 10 mg/1 | TabletOral | Major Pharmaceuticals | 0904-6619 |
| Isosorbide Dinitrate | Isosorbide dinitrate 5 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0143-1769 |
| Isosorbideisosorbide dinitrate | Isosorbide dinitrate 20 mg/1 | TabletOral | BluePoint Laboratories | 68001-375 |
| Isosorbide Dinitrate | Isosorbide dinitrate 10 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0143-1771 |
| Isosorbide Dinitrate | Isosorbide dinitrate 20 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0143-1772 |